PRKN and metabolic dysfunction-associated steatotic liver disease: Together with its ameliorative effects on markers of OS, these results indicate that ACT may improve mitochondrial function and reduce oxidative damage by activating PINK1/Parkin-related mitophagy markers, which may be a key mechanism by which it preserves mitochondrial homeostasis and ameliorates MASLD.